Transaction · 0000943819-26-000085

Farrell Michael J.

Farrell Michael J., CHAIR, reported an open-market or private sale at RESMED INC involving 4991.000000 shares for an estimated $1129637.49. Reported holdings after the transaction were 479803.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCHAIR
RMDRESMED INC
Filing timeOct 08
Trade dateOct 07, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded1.03%Shares sold ÷ (holdings after + shares sold). Estimated position before: 484,794 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$226.73
Pre-filing
1mo ago +0.7%1w ago -2.5%1d ago -2.7%
Returns since
7d30d90d180d1y

RMD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RMD since 2026-10-08Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000943819-26-000085
ResMed Common Stock
Transaction date
Oct 07, 2026
Filed Oct 08, 2026, 09:31 PM · 1d delay
Shares
4.99k sh
$226.33 per share
Estimated value
-$1.12M
Computed from shares × price
Holdings after
479k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chairman and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $222.2135 - $227.581. The price reported above reflects the weighted average sale price.

  3. F3

    Represents date options first become exercisable. Options vest 1/3 per year

Original filing · 0000943819-26-000085
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RMD